lncRNA and breast cancer: Progress from identifying mechanisms to challenges and opportunities of clinical treatment-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

lncRNA and breast cancer: Progress from identifying mechanisms to challenges and opportunities of clinical treatment

Published:2021-09 Issue: Volume:25 Page:613-637
ISSN:2162-2531
Container-title:Molecular Therapy - Nucleic Acids
language:en
Short-container-title:Molecular Therapy - Nucleic Acids

Author:

Jin Huan,Du Wei,Huang Wentao,Yan Jiajing,Tang Qing,Chen Yibing,Zou Zhengzhi

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Drug Discovery,Molecular Medicine

Reference271 articles.

1. Breast cancer;Harbeck;Lancet,2017

2. Managing therapeutic resistance in breast cancer: from the lncRNAs perspective;Peng;Theranostics,2020

3. Breast cancer;Woolston;Nature,2015

4. Long Non-Coding RNA HOTAIR in Breast Cancer Therapy;Cantile;Cancers (Basel),2020

5. The PI3K/AKT/mTOR and CDK4/6 Pathways in Endocrine Resistant HR+/HER2- Metastatic Breast Cancer: Biological Mechanisms and New Treatments;Presti;Cancers (Basel),2019

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Propofol orchestrates long non-coding RNAs in MCF7 cells, unraveling new avenues for breast cancer intervention;European Journal of Medicinal Chemistry Reports;2024-12

2. Unraveling lncRNA Diversity at a Single Cell Resolution and in a Spatial Context across Different Cancer Types;2024-08-12

3. Identification of N6-Methyladenosine-Associated lncRNAs and Analysis of Prognostic Signature in Breast Cancer;Biochemical Genetics;2024-07-23

4. Long non-coding RNAs PTENP1, GNG12-AS1, MAGI2-AS3 and MEG3 as tumor suppressors in breast cancer and their associations with clinicopathological parameters;Cancer Biomarkers;2024-05-28

5. Reprogramming tendon healing: a guide to novel molecular tools;Frontiers in Bioengineering and Biotechnology;2024-05-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3